AdvisorShares Psychedelics ETF is a ETF series of AdvisorShares Trust (series S000072085). Net assets $20.2M as of 2026-03-31.
Showing 15 of 58 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Relmada Therapeutics Inc. | RLMD | $2.1M | 1016.98% |
| Relmada Therapeutics Inc. | — | $2.1M | 1016.98% |
| ATAIBECKLEY INC | — | $2.0M | 992.28% |
| ATAIBECKLEY INC | ATAI | $2.0M | 992.28% |
| DEFINIUM THERAPEUTICS INC | DFTX | $1.7M | 852.19% |
| DEFINIUM THERAPEUTICS INC | — | $1.7M | 852.19% |
| DREY INST PREF GOV MM-M | DSVXX | $1.6M | 789.28% |
| DREY INST PREF GOV MM-M | DSVXX | $1.6M | 789.28% |
| Compass Pathways plc | CMPS | $1.4M | 673.85% |
| Compass Pathways plc | — | $1.4M | 673.85% |
| Neurocrine Biosciences Inc | NBIX | $945K | 466.48% |
| Neurocrine Biosciences Inc | — | $945K | 466.48% |
| Gh Research Plc | — | $942K | 465.46% |
| Gh Research Plc | GHRS | $942K | 465.46% |
| Cybin Inc | — | $939K | 463.68% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $20.2M |
| 2025-12-31 | $18.5M |
| 2025-09-30 | $17.1M |
| 2025-06-30 | $10.3M |
| 2025-03-31 | $8.7M |
| 2024-12-31 | $6.3M |
| 2024-09-30 | $4.4M |
| 2024-06-28 | $5.6M |